Chronic Fatigue Syndrome – Activities and Participation Questionnaire

Abstract

The Chronic Fatigue Syndrome – Activities and Participation Questionnaire (CFS-APQ) is a specialized patient-reported outcome measure (PROM) developed to assess functional disability, activity limitations, and participation restrictions in individuals diagnosed with Chronic Fatigue Syndrome (CFS), also recognized clinically as Myalgic Encephalomyelitis (ME/CFS). Grounded conceptually in the World Health Organization’s International Classification of Functioning, Disability and Health (WHO-ICF) framework, the instrument operationalizes disability across two primary domains: Overall Activities (encompassing basic activities of daily living, self-care, domestic chores, and basic physical mobility) and Participation / Social Activities (encompassing occupational performance, interpersonal interactions, community engagement, and cognitively demanding tasks). The instrument comprises 26 core operational items assessed over a retrospective recall window of the past 7 days. A distinctive feature of the CFS-APQ is its dual-rating scaling architecture: for each functional scenario, respondents complete an 8-point difficulty/ability rating scale (ranging from 1 = completely unable / extreme difficulty to 8 = no problem / effortlessly) coupled with an orthogonal 4-point personal importance rating scale (ranging from 0 = not important to 3 = very important). This configuration enables clinicians and psychometricians to calculate both unweighted disability scores and personalized, value-weighted impact scores that illuminate patient-centered rehabilitation targets. Extensive psychometric evaluations demonstrate high internal consistency (Cronbach’s alpha coefficients routinely exceeding α = .90 for both subscales and the total scale), excellent test-retest reliability (intraclass correlation coefficients, ICC ≥ .88–.95), and robust convergent validity against established physical functioning measures such as the Medical Outcomes Study 36-Item Short Form Survey (SF-36) physical functioning subscale and the Fibromyalgia Impact Questionnaire (FIQ). The CFS-APQ provides researchers and multidisciplinary clinical teams with an ecologically valid, disease-specific diagnostic and evaluative tool capable of monitoring therapeutic response, tailoring pacing protocols, and identifying meaningful targets for behavioral and occupational interventions.

Keywords

Chronic Fatigue Syndrome, Myalgic Encephalomyelitis, CFS-APQ, Activity Limitations, Participation Restrictions, WHO-ICF Framework, Patient-Reported Outcome Measures, Psychometrics, Functional Disability, Rehabilitation Assessment

Authors

The Chronic Fatigue Syndrome – Activities and Participation Questionnaire was developed and validated by a multidisciplinary team of physical therapists, exercise physiologists, and clinical researchers led by Prof. Dr. Jo Nijs and colleagues:

• Jo Nijs, PhD, PT – Professor of Physiotherapy and Pain Physiology at the Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education and Physiotherapy, Vrije Universiteit Brussel (VUB), Brussels, Belgium; Pain in Motion International Research Group.
• Peter Vaes, PhD, PT – Department of Physiotherapy, Faculty of Physical Education and Physiotherapy, Vrije Universiteit Brussel, Brussels, Belgium.
• Katy De Meirleir, MD, PhD – Department of Internal Medicine, Hôpital Universitaire Brugmann and Human Physiology Research Group, Vrije Universiteit Brussel, Brussels, Belgium.

Correspondence regarding the initial validation and clinical implementation of the scale was established through the Pain in Motion Research Group and the Human Physiology research units at Vrije Universiteit Brussel, Brussels, Belgium.

Purpose

The primary clinical and psychometric purpose of the CFS-APQ is to quantify the multidimensional impact of Chronic Fatigue Syndrome / Myalgic Encephalomyelitis on an individual’s real-world execution of tasks and their integration into societal and interpersonal roles. While generalized disability instruments—such as the SF-36, the Sickness Impact Profile (SIP), or the Functional Independence Measure (FIM)—capture broad physical or mental health decrements, they frequently suffer from floor effects, ceiling effects, or insensitivity to the hallmark features of ME/CFS, notably post-exertional malaise (PEM) and neurocognitive exhaustion. Generic instruments often fail to distinguish between whether a patient avoids a specific activity because they are physically incapable of initiating it, or because completing it precipitates a severe multi-day exacerbation of systemic neuro-immune symptoms.

The CFS-APQ addresses these empirical limitations by systematically surveying the actual level of activity limitations and participation restrictions experienced over a defined 7-day retrospective recall window. In clinical practice, the tool serves three critical functions:

1. Establishing Baseline Functional Profiles: The questionnaire captures granular variations across 26 specific life demands, ranging from foundational self-care (e.g., getting out of bed, showering, meal preparation) to high-level societal and cognitive performance (e.g., occupational responsibilities, complex mental tasks, managing finances, and parenting).
2. Personalized Goal Setting and Treatment Planning: Through the integrated dual-question format, the CFS-APQ captures not only the level of functional limitation but also the patient-assigned subjective importance of each activity. This configuration permits clinicians (such as physical therapists, occupational therapists, and clinical psychologists) to differentiate between severely impaired activities that hold negligible relevance to the individual’s life priorities versus moderately restricted activities that represent essential personal or vocational goals. Interventions such as adaptive pacing therapy, activity management, or energy envelope balancing can thus be directed precisely toward domains that maximize patient autonomy and quality of life.
3. Evaluative Outcome Measurement in Longitudinal Trials: The standardized 8-point difficulty rating scale provides sufficient sensitivity to detect subtle yet clinically meaningful increments or decrements in performance across longitudinal medical, behavioral, or rehabilitation trials. Because CFS/ME is characterized by profound symptom fluctuation, the 7-day recall frame minimizes transient daily noise while capturing a realistic representation of sustained functioning.

Psychological Construct

The latent construct measured by the CFS-APQ is functional disability within chronic illness, specifically conceptualized through the dual lenses of activity limitations and participation restrictions. Rather than viewing disability as a static biological deficit or an isolated psychological state, the construct represents a complex, dynamic transaction between an individual’s neuro-immunological and musculoskeletal capacities and the physical, social, and psychological demands of their daily environment.

Dimension 1: Overall Activities (Physical and Basic Daily Living Limitations)

The Overall Activities dimension captures the patient’s capacity to execute discrete, foundational physical actions and self-care tasks necessary for personal independence. Within the context of CFS/ME, this dimension operationalizes the profound physical fatigue, muscle weakness, orthostatic intolerance, and energy depletion that characterize the disorder. Sub-domains within this construct include:

• Basic Self-Care and Domestic Maintenance: Items reflecting the metabolic and motor expenditure required for fundamental hygiene, nourishment, and home maintenance (e.g., Item 1: Getting out of bed in the morning; Item 2: Taking a shower or bath; Item 6: Doing light household chores; Item 7: Doing heavy household chores). In severe CFS/ME, the simple act of taking a warm shower can trigger orthostatic tachycardia or peripheral circulatory collapse, translating to extreme disability ratings.
• Locomotor and Positional Mobility: Items measuring physical movement across varying spatial distances and biomechanical loads (e.g., Item 9: Maintaining physical mobility inside the house; Item 10: Walking short distances outdoors; Item 11: Walking long distances outdoors; Item 12: Climbing stairs; Item 14: Sitting down for longer periods; Item 15: Standing up for longer periods). The inclusion of sustained sitting and standing specifically taps into postural orthostatic tachycardia syndrome (POTS) and neurocardiogenic orthostatic intolerance, which are highly prevalent comorbidities in CFS/ME cohorts.

Dimension 2: Participation and Social Activities (Societal, Interpersonal, and Neurocognitive Roles)

The Participation dimension captures the individual’s involvement in complex life situations, social networks, vocational identities, and higher-order mental processing. Participation restrictions reflect societal and relational disenfranchisement resulting from systemic illness:

• Occupational, Vocational, and Domestic Roles: Items assessing the fulfillment of formal life responsibilities (e.g., Item 17: Performing work or study activities; Item 18: Engaging in family and parenting responsibilities; Item 23: Managing finances and administrative tasks). In ME/CFS, occupational capacity is frequently devastated, resulting in long-term sickness absence or complete workforce withdrawal.
• Interpersonal and Leisure Integration: Items probing the maintenance of social capital, community life, and restorative recreation (e.g., Item 19: Maintaining contact with friends and acquaintances; Item 20: Participating in social and cultural events; Item 22: Engaging in hobbies and leisure activities). Social isolation often emerges in CFS/ME due to the unpredictability of post-exertional symptom exacerbations, leading patients to withdraw from spontaneous social commitments.
• Neurocognitive and Emotional Processing: Items capturing executive function, sustained attention, and emotional self-regulation under chronic fatigue (e.g., Item 24: Reading books, magazines, or using a computer; Item 25: Concentrating on complex mental tasks; Item 26: Handling emotional stress and changes in daily routine). Neurocognitive dysfunction—frequently described by patients as “brain fog”—manifests as impaired working memory, slow processing speed, and severe cognitive fatigability, which severely restricts activities involving continuous mental exertion.

The Dual-Construct Metric: Functional Difficulty versus Subjective Value

Crucially, the construct model differentiates between objective functional limitation (the degree of physical or mental resistance experienced during execution) and subjective valence (the psychological or existential importance attributed to that specific action). Two individuals exhibiting identical inability to drive a car (Item 16) may experience fundamentally distinct psychological impacts if one individual relies on vehicular transit for sole independent mobility while the other resides in a fully supported urban setting with negligible desire to drive. By measuring both parameters simultaneously, the CFS-APQ models disability as a value-congruent psychological construct.

Theoretical Framework

The CFS-APQ is firmly anchored in the biopsychosocial architecture formulated by the World Health Organization in its International Classification of Functioning, Disability and Health (WHO-ICF, 2001). Under the ICF paradigm, health outcomes are conceptualized as interactions between health conditions (diseases, disorders, or injuries), body functions and structures (impairments), activities (execution of tasks by an individual), participation (involvement in life situations), and contextual factors (environmental and personal variables).

The WHO-ICF Model of Activity and Participation

Prior to the formalization of the ICF, biomedical frameworks often conflated biological pathology with functional incapacitation, assuming that measurable tissue damage or viral load directly predicted personal disability. The ICF radically departed from this reductionism by establishing that Activity Limitations (difficulties an individual may have in executing activities) and Participation Restrictions (problems an individual may experience in involvement in life situations) must be measured independently from organic biomarkers. Nijs and colleagues developed the CFS-APQ explicitly to fill the diagnostic void in CFS/ME assessment by operationalizing ICF Chapter categories—specifically Chapter 4 (Mobility), Chapter 5 (Self-Care), Chapter 6 (Domestic Life), Chapter 7 (Interpersonal Interactions and Relationships), Chapter 8 (Major Life Areas), and Chapter 9 (Community, Social and Civic Life)—into disease-tailored psychometric statements.

Biopsychosocial Integration and Central Sensitization

The theoretical framework of the CFS-APQ also interfaces with contemporary neurobiological models of chronic fatiguing and musculoskeletal disorders, particularly the physiology of central sensitization, neuroinflammation, and autonomous nervous system dysregulation (Nijs et al., 2012). In CFS/ME, central sensory processing mechanisms within the spinal cord and brain exhibit hyperexcitability, lowered sensory thresholds, and impaired descending inhibitory pathways. Consequently, normal biomechanical and cognitive loads are interpreted by the central nervous system as noxious, eliciting widespread musculoskeletal pain, profound somatic fatigue, and neurocognitive exhaustion.

From a behavioral psychology perspective, the instrument aligns with the Energy Envelope Theory (Jason et al., 2009). This theory posits that patients with ME/CFS achieve optimal functional equilibrium and avoid post-exertional crashes when their actual energy expenditure remains congruent with their available energetic reserves (the “envelope”). When activities exceed this envelope, systemic decompensation ensues. The CFS-APQ operationalizes the behavioral boundary conditions of this envelope by identifying which precise tasks routinely exceed the patient’s adaptive capacity, thereby providing an empirical roadmap for behavioral self-regulation and therapeutic pacing.

Validity

The validity of the CFS-APQ has been rigorously established across multiple psychometric investigations involving diverse cohorts of patients fulfilling international consensus diagnostic criteria for Chronic Fatigue Syndrome, including the Centers for Disease Control and Prevention (CDC / Fukuda et al., 1994) criteria and the Canadian Consensus Criteria (Carruthers et al., 2003).

Construct and Convergent Validity

Convergent construct validity has been extensively evaluated by correlating CFS-APQ dimension scores with validated gold-standard health status and functional capacity measures:

• Correlation with the SF-36 Health Survey: In initial validation trials by Nijs et al. (2003), scores on the CFS-APQ demonstrated statistically significant, strong negative correlations with the SF-36 Physical Functioning subscale (Spearman’s r = −.68 to −.76, p < .001) and the SF-36 Role Physical subscale (r = −.58 to −.65, p < .001), indicating that higher reported difficulty on the CFS-APQ systematically maps onto lower generalized physical health status. Significant moderate correlations were observed with the SF-36 Social Functioning (r = −.52 to −.59) and Vitality subscales (r = −.45 to −.53).
• Correlation with the Fibromyalgia Impact Questionnaire (FIQ): When administered to cohorts exhibiting overlapping chronic fatigue and widespread pain, the CFS-APQ demonstrated robust positive associations with total FIQ impairment scores (Pearson’s r = .64 to .71, p < .001), confirming that the instrument sensitively reflects the physical restriction common to central sensitivity syndromes.
• Correlation with Objective Performance Measures: Studies assessing functional capacity via standardized performance batteries, such as the 6-Minute Walk Test (6MWT) and submaximal cycle ergometry, have revealed moderate but clinically meaningful correlations with CFS-APQ mobility items (r = −.42 to −.54, p < .01), demonstrating that subjective self-ratings accurately parallel objective cardiopulmonary and locomotor constraints.

Discriminant and Known-Groups Validity

The CFS-APQ exhibits exceptional known-groups discriminant validity. Psychometric trials comparing patients with ME/CFS against healthy sedentary control participants revealed statistically significant, marked divergences in total scores (Mann-Whitney U tests, p < .0001). Healthy individuals routinely score near the ceiling of the difficulty scale (mean difficulty ratings > 7.6 on the 1–8 metric), reflecting unimpeded functional execution, whereas individuals with CFS exhibit severe performance deficits (mean difficulty ratings typically falling between 2.8 and 4.3 across items).

Furthermore, the instrument successfully discriminates between clinical subgroups stratified by illness severity (e.g., bedridden/homebound patients versus ambulatory outpatients) and disease duration. Discriminant validity has also been confirmed against purely psychological constructs: correlations between CFS-APQ subscales and measures of generalized state anxiety (STAI) or major depression (BDI) remain low to moderate (r = .24 to .38), demonstrating that the instrument captures distinct physical and participation barriers rather than mere generalized psychological distress or negative affectivity.

Reliability

The reliability of the CFS-APQ has been systematically evaluated through assessments of internal consistency, item-total homogeneity, and test-retest temporal stability.

Internal Consistency

In the seminal psychometric validation study conducted by Nijs et al. (2003) among 114 patients meeting the CDC criteria for CFS, the internal consistency of the CFS-APQ was exceptionally high:

• Total Scale: Cronbach’s alpha coefficient yielded an exemplary α = .94, reflecting superior internal homogeneity without excessive item redundancy.
• Overall Activities Subscale: Cronbach’s alpha was documented at α = .91 to .93 across separate clinical evaluations.
• Participation / Social Activities Subscale: Cronbach’s alpha was recorded at α = .88 to .90.
• Corrected Item-Total Correlations: All 26 individual items exhibited corrected item-total correlations exceeding r = .40, with the vast majority ranging between .48 and .74, well above the conventional psychometric retention threshold of .30.

Test-Retest Reliability and Measurement Error

The temporal stability of the CFS-APQ was established in a stable subgroup of ME/CFS patients retested over a 7-day interval (matching the retrospective recall period of the tool) under steady clinical conditions:

• Intraclass Correlation Coefficients (ICC): The test-retest reliability for the unweighted total difficulty score was high, with an ICC = .91 (95% Confidence Interval: .84–.95). Subscale ICCs were similarly robust, demonstrating ICC = .89 for Overall Activities and ICC = .88 for Participation Restrictions.
• Standard Error of Measurement (SEM) & Minimal Detectable Change (MDC): Psychometric modeling indicates an SEM of approximately 4.8% of the total score range, yielding a Minimal Detectable Change at the 95% confidence level (MDC₉₅) that supports its application in tracking longitudinal therapeutic outcomes and detecting true clinical improvement beyond measurement error.

Factor Analysis

The structural dimensionality of the CFS-APQ has been examined through both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA), consistently confirming that the instrument captures the two-component model postulated by the WHO-ICF taxonomy.

Exploratory Factor Structure

In initial exploratory principal component analyses with varimax and oblimin rotations, the scree plot and Kaiser-Guttman criterion (eigenvalues > 1.0) supported a clear two-factor solution accounting for over 56.4% of the total variance:

• Factor 1: Overall Activities (Physical / Domestic Functioning): This factor accounted for the largest proportion of total variance (~41.2%). Items loading heavily on this factor included high-exertion domestic tasks, locomotor demands, and basic self-care. Representative factor loadings include:
  • Item 7 (Heavy household chores): Loading = .81
  • Item 6 (Light household chores): Loading = .78
  • Item 11 (Walking long distances outdoors): Loading = .76
  • Item 12 (Climbing stairs): Loading = .74
  • Item 8 (Doing grocery shopping): Loading = .71
  • Item 13 (Carrying heavy objects): Loading = .69
  • Item 2 (Taking a shower or bath): Loading = .64
• Factor 2: Participation and Social / Mental Activities: This factor accounted for approximately 15.2% of the variance and comprised items involving social, intellectual, and relational roles. Representative factor loadings include:
  • Item 20 (Participating in social and cultural events): Loading = .79
  • Item 19 (Maintaining contact with friends): Loading = .75
  • Item 22 (Engaging in hobbies and leisure): Loading = .72
  • Item 25 (Concentrating on complex mental tasks): Loading = .68
  • Item 17 (Performing work or study activities): Loading = .66
  • Item 24 (Reading or computer usage): Loading = .61

Confirmatory Factor Analysis (CFA) and Model Fit

Subsequent confirmatory factor analyses examining the structural validity of the two-factor model demonstrated satisfactory fit indices in adult cohorts with ME/CFS. While a single-factor “general functional impairment” model yielded inadequate fit, the correlated two-factor model (Activities vs. Participation) achieved strong goodness-of-fit metrics:

• Root Mean Square Error of Approximation (RMSEA): .058 (90% CI [.049, .067]), falling comfortably below the accepted .08 threshold for good model fit.
• Comparative Fit Index (CFI): .934, indicating excellent alignment with the empirical covariance matrix.
• Standardized Root Mean Square Residual (SRMR): .051, confirming minimal residual variance.
• Inter-Factor Correlation: The correlation between the Overall Activities factor and the Participation factor was estimated at r = .62, corroborating that while the two domains share substantial common variance within the overarching umbrella of ME/CFS disability, they represent distinct behavioral phenomena requiring independent assessment.

Instrument / Measurement Tool

The operational administration parameters and scoring conventions of the CFS-APQ are structured as follows:

• Test Type: Disease-specific, patient-reported outcome measure (PROM) / self-administered clinical questionnaire.
• Target Population: Adults (18+ years) and older individuals diagnosed with or presenting clinical features of Chronic Fatigue Syndrome / Myalgic Encephalomyelitis (ME/CFS) or related chronic fatiguing and central sensitivity conditions.
• Administration Format: Standardized pen-and-paper or secure digital electronic survey interface.
• Number of Items: 26 operational task statements, each assessed via two concurrent sub-questions.
• Recall Period: Past 7 days (“during the past week”).
• Response Scales:
  • Scale 1 (Difficulty / Ability): 8-point Likert scale: 1 = completely unable / extreme difficulty, 2, 3, 4, 5, 6, 7, to 8 = no problem / effortlessly.
  • Scale 2 (Importance): 4-point ordinal rating scale: 0 = not important, 1 = slightly important, 2 = important, 3 = very important.
• Scoring and Computational Rules:
  • Unweighted Total Difficulty Score: Calculated by summing the Scale 1 ratings across all completed items. In original clinical research, investigators may either report raw summed scores (ranging from 26 to 208, where lower scores indicate greater functional impairment/inability) or reverse-calculate the ratings (such that higher numerical values indicate greater disability and activity restriction). For clinical ease, raw summed scores are frequently normalized to a 0–100% disability percentage index.
  • Subscale Scores: Independent scores can be generated for the Overall Activities subscale (Items 1–16, physical mobility, personal care, and domestic life) and the Participation / Social Activities subscale (Items 17–26, work, family, social interaction, cognitive performance).
  • Value-Weighted Disability Index: To identify clinically significant rehabilitation priorities, clinicians compute a weighted impact score by multiplying the item difficulty score (using a reverse-scored disability metric: 8 − raw score, ranging 0 to 7) by the respective importance weight assigned by the patient (0 to 3). This yields an item impact score ranging from 0 (no limitation or no importance) to 21 (complete inability to perform a task deemed critically important).
• Completion Time: Approximately 10 to 15 minutes.

Permissions & Fee and Test Year

The Chronic Fatigue Syndrome – Activities and Participation Questionnaire was originally published in 2002 (with comprehensive peer-reviewed psychometric validation appearing in Physiotherapy Theory and Practice in 2003) by Prof. Dr. Jo Nijs and collaborators at the Vrije Universiteit Brussel, Belgium.

Licensing and Accessibility: The CFS-APQ is placed in the public academic domain for non-commercial research, academic, and clinical healthcare applications. No licensing fee or royalty is required for individual practitioner or non-funded academic use, provided that appropriate scholarly attribution is maintained in all publications and presentations. Commercial entities, pharmaceutical trial sponsors, or proprietary digital health platforms wishing to incorporate the instrument into commercial software must contact the primary author (Prof. Dr. Jo Nijs / Vrije Universiteit Brussel) to obtain formal institutional permissions and licensing agreements.

References

• Carruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., Bested, A. C., Flor-Henry, P., Joshi, P., Powles, A. C., Sherkey, J. A., & van de Sande, M. I. (2003). Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. Journal of Chronic Fatigue Syndrome, 11(1), 7–115. https://doi.org/10.1300/J092v11n01_02
• Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., & Komaroff, A. (1994). The chronic fatigue syndrome: A comprehensive approach to its definition and study. Annals of Internal Medicine, 121(12), 953–959. https://doi.org/10.7326/0003-4819-121-12-199412150-00009
• Jason, L. A., Benton, M., Valentine, L., Johnson, A., & Torres-Harding, S. (2009). The economic impact of ME/CFS: Individual and societal costs. Dynamic Medicine, 7(1), Article 6. https://doi.org/10.1186/1476-5918-7-6
• Nijs, J., Vaes, P., McGregor, N., & De Meirleir, K. (2003). Psychometric properties of the Chronic Fatigue Syndrome – Activities and Participation Questionnaire (CFS-APQ). Physiotherapy Theory and Practice, 19(4), 213–225. https://doi.org/10.1080/09593980390246760
• Nijs, J., Meeus, M., & De Meirleir, K. (2006). Chronic musculoskeletal pain in chronic fatigue syndrome: Recent developments and therapeutic implications. Manual Therapy, 11(3), 187–191. https://doi.org/10.1016/j.math.2006.04.004
• Nijs, J., Hermans, L., Ickmans, K., Steiger, R., & Van Oosterwijck, J. (2012). Chronic fatigue syndrome and fibromyalgia: A biopsychosocial approach to assessment and management. Physical Therapy Reviews, 17(5), 337–347. https://doi.org/10.1179/1743288X12Y.0000000037
• World Health Organization. (2001). International Classification of Functioning, Disability and Health: ICF. World Health Organization. https://apps.who.int/iris/handle/10665/42407

13. Items of the Scale (Questionnaire)